Chrysalin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2015
01220042015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
In recent years, increasing threats of radiation exposure and nuclear disasters have become a significant concern for the United… (More)
  • figure 1
  • figure 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Endothelial dysfunction (ED) is characterized by impaired nitric oxide (NO) signaling, decreased NO-dependent vasodilatation… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2008
Review
2008
Rusalatide acetate (Chrysalin) is an investigational drug being evaluated for treatment of chronic wounds and fractures… (More)
Is this relevant?
2007
2007
Thrombin and thrombin peptides play a role in initiating tissue repair. The potential safety and efficacy of TP508 (Chrysalin… (More)
Is this relevant?
Review
2006
Review
2006
The thrombin peptide, TP508, also known as Chrysalin (OrthoLogic, Tempe, Arizona), is a twenty-three-amino-acid peptide that… (More)
Is this relevant?
Review
2005
Review
2005
OrthoLogic (formerly Chrysalis) is developing Chrysalin, a synthetic 23-amino acid peptide that mimics a portion of human… (More)
Is this relevant?
Review
2004
Review
2004
The synthetic peptide, TP508 (Chrysalin), was delivered to rabbit segmental bone defects in biodegradable controlled-release PLGA… (More)
Is this relevant?